ArticleBMC genomics2025
TDO-mediated tissue-specific regulation of kynurenine pathway in the brain and gill of Litopenaeus vannamei.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe kynurenine pathway (KP), central to tryptophan metabolism, regulates neuroimmune interactions in vertebrates through the dual actions of indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO). However, crustaceans lack IDO and rely solely on TDO, yet the tissue-specific roles of TDO in this lineage remain unknown. Using Litopenaeus vannamei, a key aquaculture species, we investigated how TDO-mediated KP adapts to functional constraints in neural and respiratory tissues.
resultsGenomic analyses confirmed the absence of IDO in crustaceans, while LvTDO retained catalytic domains homologous to vertebrates but acquired lineage-specific structural features. Tissue-specific profiling revealed dominant LvTDO expression in brain and gill. RNAi knockdown triggered distinct responses: the brain upregulated oxidative phosphorylation and cytoskeletal pathways but suppressed neural signaling, whereas the gill activated apoptosis and immune pathways while downregulating glycolysis. KEGG analysis further highlighted hypoxia adaptation in gill (HIF-1 pathway) and stress signaling in brain (MAPK/Hippo).
conclusionsOur findings suggest that L. vannamei may compensate for IDO absence via tissue-specific TDO regulation, with brain-gill axis specialization reflecting adaptive metabolic plasticity. While structural divergences in LvTDO hint at evolutionary innovations, functional equivalence to vertebrate IDO/TDO systems requires further validation. This study highlights the evolutionary flexibility of KP in invertebrates, though metabolite dynamics and long-term physiological impacts remain to be explored.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.